$AIFF Cashflow Statement | Understand Stock

$AIFF

$1.00 +$0.06 (6.33%) Close

$AIFF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Loss from discontinued operations
Depreciation and amortization
Impairment of long-lived assets
Goodwill impairment
Gray Matters
Total goodwill impairment
Interest and bank fees
Change in derivative fair value
Impairment of intangible assets
Other income (expenses)
Share-based compensation expense
Deferred income tax expense
Amortization of right-of-use assets
Accretion of deferred acquisition consideration
Change in fair value of contingent consideration
Gain on litigation settlement
Gain on sale of equity investment and settlement of contingent consideration receivable
Equity in loss of affiliate
Shares and warrants issued for consulting services
Accretion expense on convertible promissory note
Loss on settlement of convertible promissory note
Loss on shares issued for debt
Drawdown in shares issued for prepaid services

Changes in operating assets and liabilities:
Change in accounts receivable
Change in prepaid expenses and deposits
Contract assets
Other assets
Change in inventories
Change in accounts payable
Nonrelated Party
Related Party
Total change in accounts payable
Change in accrued liabilities
Operating lease liability
Commissions payable
Cash used in operating activities of continuing operations
Cash used in operating activities of discontinued operations
Change in deferred revenue
Net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of property and equipment
Proceeds from sale of equity investment and settlement of contingent consideration receivable
Proceeds from disposal of business
Acquisition of new businesses, net of cash acquired
Tellenger, Inc.
Gray Matters
New Business Acquisitions
The Merger
Total acquisition of new businesses, net of cash acquired

Product enhancements – intangible asset
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowing under revolving line of credit
Borrowings under notes payable
Repayments of notes payable
Borrowing under long-term note
Repayments of long-term note
Borrowings under revolving line of credit
Repayments under revolving line of credit
Premium financing borrowings
Premium financing repayments
Proceeds from issuance of stock
Proceeds from exercise of stock options
Proceeds from issuance of convertible promissory note, net of transaction costs
Proceeds from exercise of warrants
Proceeds from sale of shares, net of issuance costs
Net cash provided by financing activities
INCREASE (DECREASE) IN CASH
BALANCE OF CASH AT THE BEGINNING OF YEAR
BALANCE OF CASH AT THE END OF YEAR

Supplemental cash flow information
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities
Forgiveness of note payable
Deferred and contingent consideration in connection with the acquisition of Gray Matters, Inc.
Non-cash proceeds on disposal of business
Deemed issuance of shares to former shareholders’ of WaveDancer
Product enhancements - intangible asset in accounts payable and accrued liabilities
Shares issued
Common Stock Purchase Agreement
Tellenger, Inc.
Gray Matters
Evoke Neuroscience, Inc.
Shares Issued for Prepaid Services
Total shares issued

Shares issued for debt
Conversion of Debt Into Common Stock
Shares Issued for Conversion of Promissory Notes
PPE transferred from inventory
Deemed dividend on warrant inducement
Payments to acquire equipment

Comments